What is the clinical use and interpretation of the PLASMIC (Pulmonary Embolism Likelihood Assessment Using a Modified Score Incorporating Clinical factors) score in diagnosing pulmonary embolism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

PLASMIC Score: Clarification and Correct Clinical Application

Critical Clarification: PLASMIC vs. Pulmonary Embolism Scores

The PLASMIC score is NOT used for diagnosing pulmonary embolism—it is a clinical prediction tool for thrombotic thrombocytopenic purpura (TTP). The question appears to conflate PLASMIC with pulmonary embolism assessment tools. For PE diagnosis, clinicians should use validated scores including Wells criteria, Geneva score, or PERC (Pulmonary Embolism Rule-Out Criteria) 1.

Validated Clinical Decision Tools for Pulmonary Embolism

Wells Criteria

  • The Wells score stratifies patients into low, intermediate, or high pretest probability categories to guide D-dimer testing and imaging decisions 1.
  • Low-risk patients (Wells score <2) have approximately 3% PE prevalence, while high-risk patients (score >6) have 36% prevalence 1.
  • The Wells criteria have been externally validated and perform similarly to clinician gestalt and the Geneva score 1.

Geneva Score (Revised and Simplified)

  • The revised Geneva score uses 8 clinical variables including age >65 years, previous DVT/PE, recent surgery, active malignancy, unilateral leg pain, hemoptysis, heart rate categories, and lower limb findings 2.
  • PE prevalence is 8% in low-probability (0-3 points), 28% in intermediate-probability (4-10 points), and 74% in high-probability (≥11 points) categories 2.
  • The simplified Geneva score (SGS) assigns one point to each variable, making it easier to memorize and apply, with equivalent safety and efficiency to the original version 3.

PERC (Pulmonary Embolism Rule-Out Criteria)

  • PERC should only be applied to patients already determined to have LOW pretest probability to identify those in whom testing risks outweigh PE risk 1, 4, 5.
  • All 8 PERC criteria must be met: age <50 years, heart rate <100 bpm, oxygen saturation ≥95%, no unilateral leg swelling, no hemoptysis, no recent trauma/surgery, no prior VTE, and no hormone use 1, 4.
  • When PERC-negative in low-risk patients, no D-dimer or imaging is needed—PE is safely excluded with only 0.3% miss rate 1, 4, 5.

Diagnostic Algorithm for Suspected PE

Step 1: Assess Pretest Probability

  • Use Wells criteria, Geneva score, or experienced clinician gestalt to categorize as low, intermediate, or high probability 1.
  • Clinician gestalt performs similarly to structured tools but lacks standardization, making decision tools preferable for less experienced clinicians 1.

Step 2: Apply PERC (Low Probability Only)

  • If low pretest probability AND all 8 PERC criteria met: stop—no further testing needed 1, 4, 5.
  • If PERC-positive (any criterion not met), proceed to D-dimer testing 4, 5.

Step 3: D-Dimer Testing

  • For patients ≤50 years: use standard cutoff of <500 ng/mL to exclude PE 1.
  • For patients >50 years: use age-adjusted cutoff (age × 10 ng/mL) to maintain 97% sensitivity while significantly improving specificity 1, 4.
  • Age-adjusted D-dimer increases specificity from 14.7% to 35.2% in patients >80 years 4.
  • Normal D-dimer (by appropriate cutoff) in low or intermediate probability patients safely excludes PE—no imaging needed 1.

Step 4: Imaging for Elevated D-Dimer or High Probability

  • Elevated D-dimer or high pretest probability requires CT pulmonary angiography (CTPA) 5.
  • If CTPA contraindicated, use ventilation-perfusion (V/Q) scan or lower extremity venous ultrasound 5.

Critical Pitfalls to Avoid

Common Errors in Clinical Practice

  • Clinical probability scores are calculated in only 0.6% of suspected PE cases, and diagnostic algorithms are not followed in 54% of patients 6.
  • Never apply PERC to intermediate or high-risk patients—this leads to missed diagnoses 4.
  • Never use PERC as a screening tool for all respiratory symptoms—only apply after determining low pretest probability 1, 4.
  • Don't use standard 500 ng/mL D-dimer cutoff in patients >50 years—this causes unnecessary imaging due to poor specificity 4.
  • Don't apply age-adjusted D-dimer to patients <50 years—standard cutoff is appropriate for this population 4.

Inpatient Considerations

  • D-dimer specificity is lower in inpatients than ED/outpatients due to comorbidities, but testing remains appropriate as sensitivity stays high 1.
  • A normal D-dimer with appropriate pretest stratification prevents unnecessary imaging even in hospitalized patients 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Age-Adjusted D-Dimer Testing for Pulmonary Embolism Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Low Suspicion Pulmonary Embolism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.